Talat Imran is Chief Executive Officer of Rani Therapeutics Holdings, Inc.. Currently has a direct ownership of 494,751 shares of RANI, which is worth approximately $702,546. The most recent transaction as insider was on Dec 09, 2024, when has been sold 10,296 shares (Class A Common Stock) at a price of $1.94 per share, resulting in proceeds of $19,974. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 495K
2.13% 3M change
2.13% 12M change
Total Value Held $702,546

Talat Imran Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 09 2024
BUY
Open market or private purchase
$19,974 $1.94 p/Share
10,296 Added 2.04%
494,751 Class A Common Stock
Dec 06 2023
BUY
Open market or private purchase
$22,700 $2.27 p/Share
10,000 Added 2.02%
484,455 Class A Common Stock
Dec 04 2023
BUY
Open market or private purchase
$12,850 $2.57 p/Share
5,000 Added 1.04%
474,455 Class A Common Stock
Nov 29 2023
BUY
Open market or private purchase
$41,000 $2.05 p/Share
20,000 Added 4.09%
469,455 Class A Common Stock
Nov 07 2023
BUY
Open market or private purchase
$10,000 $2.0 p/Share
5,000 Added 1.1%
449,455 Class A Common Stock
Mar 27 2023
BUY
Grant, award, or other acquisition
-
353,500 Added 44.3%
444,445 Class A Common Stock
Mar 22 2023
SELL
Payment of exercise price or tax liability
$47,528 $5.95 p/Share
7,988 Reduced 8.07%
90,945 Class A Common Stock
Mar 22 2022
BUY
Grant, award, or other acquisition
-
86,600 Added 46.67%
98,943 Class A Common Stock
TI

Talat Imran

Chief Executive Officer
San Jose, CA

Track Institutional and Insider Activities on RANI

Follow Rani Therapeutics Holdings, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RANI shares.

Notify only if

Insider Trading

Get notified when an Rani Therapeutics Holdings, Inc. insider buys or sells RANI shares.

Notify only if

News

Receive news related to Rani Therapeutics Holdings, Inc.

Track Activities on RANI